{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1045.31","meta":{"versionId":"18","lastUpdated":"2016-03-31T01:00:12.000-04:00","profile":["http://hl7.org/fhir/StructureDefinition/shareablevalueset","http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-author","valueString":"Lantana EH Author"},{"url":"http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate","valueDate":"2022-12-15"},{"url":"http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate","valueDate":"2016-03-31"}],"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.31","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113762.1.4.1045.31"}],"version":"20160331","name":"OtherAnticoagulantsForAcuteMyocardialInfarctionAMI","title":"Other Anticoagulants for Acute Myocardial Infarction (AMI)","status":"active","experimental":false,"date":"2016-03-31T01:00:12-04:00","publisher":"Lantana EH Steward","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"US"}]}],"purpose":"(Clinical Focus: This set of values contains medications that are prescribed for anticoagulant therapy at hospital discharge for patients following acute myocardial infarction.),(Data Element Scope: The intent of this data element is to identify patients who are prescribed anticoagulant therapy at discharge following acute myocardial infarction. Using the Quality Data Model, this particular element would map to the Medication, Discharge data type.),(Inclusion Criteria: The following list of medications should be included:\napixaban\ndabigatran\nEliquis\nPradaxa\nrivaroxiban\nXarelto),(Exclusion Criteria: None.)","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","concept":[{"code":"1037045","display":"dabigatran etexilate 150 MG Oral Capsule"},{"code":"1037179","display":"dabigatran etexilate 75 MG Oral Capsule"},{"code":"1114198","display":"rivaroxaban 10 MG Oral Tablet"},{"code":"1232082","display":"rivaroxaban 15 MG Oral Tablet"},{"code":"1232086","display":"rivaroxaban 20 MG Oral Tablet"},{"code":"1364435","display":"apixaban 2.5 MG Oral Tablet"},{"code":"1364445","display":"apixaban 5 MG Oral Tablet"},{"code":"1723476","display":"dabigatran etexilate 110 MG Oral Capsule"}]}]},"expansion":{"identifier":"urn:uuid:3f60decb-ef24-40c8-a848-2e9613406183","timestamp":"2023-12-10T20:50:05-05:00","total":8,"contains":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1037045","display":"dabigatran etexilate 150 MG Oral Capsule"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1037179","display":"dabigatran etexilate 75 MG Oral Capsule"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1114198","display":"rivaroxaban 10 MG Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1232082","display":"rivaroxaban 15 MG Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1232086","display":"rivaroxaban 20 MG Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1364435","display":"apixaban 2.5 MG Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1364445","display":"apixaban 5 MG Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1723476","display":"dabigatran etexilate 110 MG Oral Capsule"}]}}